1 year return (CAGR)
-34.15%
Genomma Lab Internacional S.A.B. de C.V Exchange (MX, MXN)
LABB.MX
12.86
-0.22 (-1.72%)
HealthcareDrug Manufacturers - Specialty & Generic
Loading...
3 year return (CAGR)
-4.23%
5 year return (CAGR)
-8.78%
10 year return (CAGR)
-4.65%
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
12.29B
Price/Sales
0.71
Ent value
22.27B
Price/Book
1.04
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
36.67%
Trailing P/E
7.96
PEG
-
Forward P/E
6.36
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 12.85 |
| Daily high | 12.85 |
| Daily low | 12.37 |
| Daily Volume | 3.64M |
| All-time high | 39.50 |
| 1y analyst estimate | 21.67 |
| Beta | 0.13 |
| EPS (TTM) | 1.58 |
| Dividend per share | 0.00 |
| Ex-div date | 29 Sep 2026 |
| Next earnings date | 25 Feb 2026 |
Downside potential
Loading...
Downside potential data
| LABB.MX | S&P500 | |
| Current price drop from All-time high | -67.44% | -1.06% |
| Highest price drop | -74.36% | -56.47% |
| Date of highest drop | 2 Feb 2009 | 9 Mar 2009 |
| Avg drop from high | -40.02% | -10.67% |
| Avg time to new high | 57 days | 12 days |
| Max time to new high | 3258 days | 1805 days |
News
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company") today announced that it will report its Third Quarter 2026 Earnings Results on Wednesday, October 21, 2026, after...
October 1, 2026
Genomma Lab Internacional, S.A.B. de C.V.(BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international p...
September 22, 2026
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Latin America with operations in 18 cou...
September 17, 2026
Genomma Lab Internacional, S.A.B. de C.V.(BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international r...
August 31, 2026
Despite a decline in net sales, Genomma Lab Internacional SAB de CV (GNMLF) focuses on innovation and market share growth to counteract economic headwinds.
July 25, 2026
Genomma Lab Internacional, S.A.B. de C.V.(BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international r...
July 22, 2026
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company") today announced that it will report its Second Quarter 2026 Earnings Results on Wednesday, July 22, 2026, after t...
July 6, 2026
Genomma Lab Internacional, S.A.B. de C.V.(BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international p...
June 29, 2026
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company") today announced that it will report its First Quarter 2026 Earnings Results on Wednesday, April 22, 2026, after t...
April 13, 2026
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter 2026. All figures included herein are stated in nominal Mexican p...
April 23, 2026